![Saul Yedgar](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Saul Yedgar
Corporate Officer/Principal bij The Hebrew University of Jerusalem
Actieve functies van Saul Yedgar
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
The Hebrew University of Jerusalem | Corporate Officer/Principal | 01-01-1982 | - |
Loopbaan van Saul Yedgar
Eerdere bekende functies van Saul Yedgar
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Institut Curie
![]() Institut Curie Miscellaneous Commercial ServicesCommercial Services Institut Curie engages as a non-profit foundation. It operates a research center on biophysics, cell biology, and oncology and a hospital specialized in treatment of cancer. The company was founded in 1909 and is headquartered in Paris, France. | Corporate Officer/Principal | - | - |
National Institutes of Health
![]() National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - | - |
Celsus Therapeutics Plc
![]() Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | Directeur/Bestuurslid | 07-09-2011 | - |
Hoofd Techniek/Wetenschap/O&O | 07-09-2011 | - |
Opleiding van Saul Yedgar
The Hebrew University of Jerusalem | Doctorate Degree |
Bar-Ilan University | Undergraduate Degree |
Statistieken
Internationaal
Israël | 3 |
Verenigd Koninkrijk | 2 |
Frankrijk | 2 |
Operationeel
Corporate Officer/Principal | 3 |
Undergraduate Degree | 2 |
Director/Board Member | 1 |
Sectoraal
Consumer Services | 3 |
Health Technology | 2 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
Celsus Therapeutics Plc
![]() Celsus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Celsus Therapeutics Plc is a drug development company, which focuses on developing novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs and multi-functional anti-inflammatory drugs. The company main clinical candidates are MRX-5, MRX-6, MRX-4, CFX-1 and OPX-1. Celsus Therapeutics was founded on October 7, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
Institut Curie
![]() Institut Curie Miscellaneous Commercial ServicesCommercial Services Institut Curie engages as a non-profit foundation. It operates a research center on biophysics, cell biology, and oncology and a hospital specialized in treatment of cancer. The company was founded in 1909 and is headquartered in Paris, France. | Commercial Services |
National Institutes of Health
![]() National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
- Beurs
- Insiders
- Saul Yedgar
- Ervaring